Immunology of Hypertension in People With HIV

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2020 Feb 18

PMID 32064997

Citations 5

Authors

Robert N Peck

Justin R Kingery

Affiliations

Soon will be listed here.

Citing Articles

Awareness, treatment, and control of hypertension among women at risk or living with HIV in the US South.

Blair J, Kempf M, Dionne J, Causey-Pruitt Z, Wise J, Jackson E AIDS. 2024; 38(11):1703-1713.

PMID: 38905486 PMC: 11293969. DOI: 10.1097/QAD.0000000000003960.

HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps.

Prakash P, Swami Vetha B, Chakraborty R, Wenegieme T, Masenga S, Muthian G Circ Res. 2024; 134(11):e150-e175.

PMID: 38781298 PMC: 11126208. DOI: 10.1161/CIRCRESAHA.124.323979.

Hypertension and human immunodeficiency virus: A paradigm for epithelial sodium channels?.

Mutengo K, Masenga S, Mwesigwa N, Patel K, Kirabo A Front Cardiovasc Med. 2022; 9:968184.

PMID: 36093171 PMC: 9452753. DOI: 10.3389/fcvm.2022.968184.

A "Return to Health" Is Associated With Blood Pressure Increase After a Year of Antiretroviral Therapy in People With HIV.

Masenga S, Povia J, Choonga M, Hamooya B Am J Hypertens. 2022; 35(11):915-917.

PMID: 35961000 PMC: 9923790. DOI: 10.1093/ajh/hpac094.

Immunology of Hypertension in People With HIV.

Peck R, Kingery J J Am Heart Assoc. 2020; 9(4):e015725.

PMID: 32064997 PMC: 7070218. DOI: 10.1161/JAHA.120.015725.

References

Madhur M, Lob H, McCann L, Iwakura Y, Blinder Y, Guzik T . Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension. 2009; 55(2):500-7. PMC: 2819301. DOI: 10.1161/HYPERTENSIONAHA.109.145094. View

Manner I, Baekken M, Kvale D, Oektedalen O, Pedersen M, Nielsen S . Markers of microbial translocation predict hypertension in HIV-infected individuals. HIV Med. 2013; 14(6):354-61. DOI: 10.1111/hiv.12015. View

van Zoest R, Wit F, Kooij K, Van Der Valk M, Schouten J, Kootstra N . Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure. Clin Infect Dis. 2016; 63(2):205-13. DOI: 10.1093/cid/ciw285. View

Tenorio A, Zheng Y, Bosch R, Krishnan S, Rodriguez B, Hunt P . Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis. 2014; 210(8):1248-59. PMC: 4192039. DOI: 10.1093/infdis/jiu254. View

Fahme S, Bloomfield G, Peck R . Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms. Hypertension. 2018; 72(1):44-55. PMC: 6002926. DOI: 10.1161/HYPERTENSIONAHA.118.10893. View

Sesso H, Buring J, Rifai N, J Blake G, Gaziano J, Ridker P . C-reactive protein and the risk of developing hypertension. JAMA. 2003; 290(22):2945-51. DOI: 10.1001/jama.290.22.2945. View

Xu Y, Chen X, Wang K . Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. J Am Soc Hypertens. 2017; 11(8):530-540. DOI: 10.1016/j.jash.2017.06.004. View

Harrison D, Guzik T, Lob H, Madhur M, Marvar P, Thabet S . Inflammation, immunity, and hypertension. Hypertension. 2010; 57(2):132-40. PMC: 3028593. DOI: 10.1161/HYPERTENSIONAHA.110.163576. View

Batavia A, Severe P, Lee M, Apollon A, Zhu Y, Dupnik K . Blood pressure and mortality in a prospective cohort of HIV-infected adults in Port-au-Prince, Haiti. J Hypertens. 2018; 36(7):1533-1539. PMC: 5976542. DOI: 10.1097/HJH.0000000000001723. View

10.

Masenga S, Elijovich F, Hamooya B, Nzala S, Kwenda G, Heimburger D . Elevated Eosinophils as a Feature of Inflammation Associated With Hypertension in Virally Suppressed People Living With HIV. J Am Heart Assoc. 2020; 9(4):e011450. PMC: 7070208. DOI: 10.1161/JAHA.118.011450. View

11.

Morimoto H, Simao A, de Almeida E, Ueda L, Oliveira S, de Oliveira N . Role of metabolic syndrome and antiretroviral therapy in adiponectin levels and oxidative stress in HIV-1 infected patients. Nutrition. 2014; 30(11-12):1324-30. DOI: 10.1016/j.nut.2014.03.017. View

12.

Peck R, Kingery J . Immunology of Hypertension in People With HIV. J Am Heart Assoc. 2020; 9(4):e015725. PMC: 7070218. DOI: 10.1161/JAHA.120.015725. View

13.

Shah A, Stelzle D, Lee K, Beck E, Alam S, Clifford S . Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis. Circulation. 2018; 138(11):1100-1112. PMC: 6221183. DOI: 10.1161/CIRCULATIONAHA.117.033369. View

14.

. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of.... Lancet. 2018; 392(10159):1923-1994. PMC: 6227755. DOI: 10.1016/S0140-6736(18)32225-6. View

15.

Hunt P . HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep. 2012; 9(2):139-47. DOI: 10.1007/s11904-012-0118-8. View

16.

Armah K, Chang C, Baker J, Ramachandran V, Budoff M, Crane H . Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans. Clin Infect Dis. 2013; 58(1):121-9. PMC: 3864500. DOI: 10.1093/cid/cit652. View

17.

Pirro M, Mannarino M, Francisci D, Schiaroli E, Bianconi V, Bagaglia F . Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy. Sci Rep. 2016; 6:28741. PMC: 4926110. DOI: 10.1038/srep28741. View

18.

Okello S, Asiimwe S, Kanyesigye M, Muyindike W, Boum 2nd Y, Mwebesa B . D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda. J Acquir Immune Defic Syndr. 2016; 73(4):396-402. PMC: 5085880. DOI: 10.1097/QAI.0000000000001074. View

19.

Guzik T, Mikolajczyk T . In search of the T cell involved in hypertension and target organ damage. Hypertension. 2014; 64(2):224-6. DOI: 10.1161/HYPERTENSIONAHA.114.03340. View

20.

Farahani M, Mulinder H, Farahani A, Marlink R . Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2016; 28(7):636-650. DOI: 10.1177/0956462416632428. View